BILINSKY IGOR — SEC Form 4 Insider Trading Activity

Summary

Updated Jul 16, 2026

BILINSKY IGOR has filed 2 SEC Form 4 filings across 1 company in the last 90 days.

Profile

Igor Bilinsky is the Chief Operating Officer of Iovance Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on cancer treatment through personalized T-cell therapies. He has been involved in the company through various SEC filings, indicating his active role in the organization.

Board memberships

• Iovance Biotherapeutics, Inc.

Awards & honors

• Chief Operating Officer at Iovance Biotherapeutics
• Involved in clinical-stage biopharmaceutical development

Recent Transactions

Companies — Last 90 Days

• IOVANCE BIOTHERAPEUTICS, INC. (IOVA) — 2 filings, last 2026-06-09

Frequently Asked Questions

Who is BILINSKY IGOR?

Igor Bilinsky is the Chief Operating Officer of Iovance Biotherapeutics, Inc., a clinical-stage biopharmaceutical company focused on cancer treatment through personalized T-cell therapies. He has been involved in the company through various SEC filings, indicating his active role in the organization.…

How many SEC Form 4 filings has BILINSKY IGOR submitted recently?

2 primary Form 4 filings in the last 90 days, covering 1 company.

Where can I see all of BILINSKY IGOR's SEC filings?

All Form 4 filings, transaction values, and 10b5-1 plan flags are listed on this page and updated in real time as new SEC EDGAR filings are processed.

Learn More

• What is SEC Form 4?
• How to read insider buying signals
• Understanding Rule 10b5-1 trading plans
• Browse all insiders
• Most active insiders this week